Elsevier

Brain and Development

Volume 18, Issue 2, March–April 1996, Pages 105-109
Brain and Development

Hematologic manifestations and impaired liver synthetic function during valproate monotherapy

https://doi.org/10.1016/0387-7604(95)00139-5Get rights and content

Abstract

In a prospective study 50 children with new onset epilepsy were investigated. Routine screening for complete blood count, serum protein, albumin, y-glutamyltransferase (γ-GT), aspartate aminotransferase (AST), alkaine aminotransferase (ALT), alkaline phosphatase, and coagulation studies before, 3, 6 and 9 weeks after commencement of antiepileptic therapy with valproate were carried out. Serum B12 and folate levels were also determined in 29 patients. The aim of the study was to evaluate the effect of VPA on these laboratory findings. We found a significant reduction of red blood count and platelet count, whereas MCV showed a significant upward trend. Vitamin B12 levels were elevated after starting VPA therapy. We found no elevations of liver enzymes, but a significant transient reduction of ALT after 3 and 6 weeks and significantly reduced serum protein and albumin after 3, 6 and 9 weeks. Coagulation studies revealed a significant downward trend in serum fibrinogen and upward trend in thrombin time. The other parameters showed no significant changes after onset of VPA treatment. We think that reduced red blood cell and platelet counts, and elevated MCV indicate a direct toxic effect on a hematopoietic precursor or stem cell in patients treated with VPA. Furthermore, reduced protein, albumin and fibrinogen indicate an impaired liver synthetic function in asymptomatic children treated with VPA monotherapy.

Reference (20)

  • DreifussF.E. et al.

    Valproic acid hepatic facilities: A retrospective review

    Neurology

    (1987)
  • DreifussF.E. et al.

    Valproic acid fatalities. II. U.S. experience since 1984

    Neurology

    (1988)
  • ScheffnerD. et al.

    Fatal liver failure in 16 children with valproate therapy

    Epilepsia

    (1988)
  • ZimmermanN.J. et al.

    Valproate-induced injury: analysis of 23 fatal cases

    Hepatology

    (1982)
  • ZafraniE.S. et al.

    Sodium valproate in the induction of unusual hepatotoxicity

    Hepatology

    (1982)
  • LoyningY. et al.

    Cases of serious/fatal hepatotoxicity due to valproate: recommended monitoring scheme and preliminary results

  • JeavonsP.M.

    Non-dose-related side effects of valproate

    Epilepsia

    (1984)
  • Powell-JacksonP.R. et al.

    Hepatotoxicity to sodium valproate: a review

    Gut

    (1984)
  • DooseH.

    Früherkennung von Komplikationen einer Valproattherapie im Kindesalter

    Pädiatr Praxis

    (1986)
  • LoiseauP.

    Sodium valproate, platelet dysfunction, and bleeding

    Epilepsia

    (1981)
There are more references available in the full text version of this article.

Cited by (0)

View full text